EMA grants orphan drug status to Sanofi’s Efdoralprin Alfa for rare lung disease
Efdoralprin alfa, a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein, showed superior efficacy to standard plasma-derived therapy in adults with AATD
Efdoralprin alfa, a recombinant human alpha-1 antitrypsin (AAT)-Fc fusion protein, showed superior efficacy to standard plasma-derived therapy in adults with AATD
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Efdoralprin Alfa was well tolerated, with a safety profile comparable to plasma-derived therapy
Acute therapies continue to report strong growth compared to chronic ones.
To prevent the state from facing a shortage of medical oxygen and to bolster the existing infrastructure, the SRAM & MRAM group is actively helping the state government to set up oxygen plants in multiple cities
Subscribe To Our Newsletter & Stay Updated